期刊文献+

检测CEA-mRNA、CEA和CA19-9诊断恶性胸水的应用价值 被引量:4

A study on the applied value in detection of carcinoembryonic antigen mRNA?CEA and CA19-9 for diagnosis of malignant dropsy of chest
下载PDF
导出
摘要 目的 评估检测癌胚抗原信使核糖核酸 (CEA mRNA)、CEA和CA19 9指标在诊断与鉴别诊断恶性胸水方面的应用价值。方法 研究对象包括恶性胸水组 5 8例、良性胸水组 5 8例 ,采集胸水为检测标本 ,应用磁酶免技术(MAIA)检测CEA和CA19 9、反转录套式聚合酶链反应 (RT NP PCR)技术检测CEA mRNA。结果 恶性胸水组 ,CEA mRNA、CEA和CA19 9的阳性率分别为 79.3 % (4 6/ 5 8)、5 1.7% (3 0 / 5 8)和 5 5 .2 % (3 2 / 5 8) ;良性胸水组 ,CEA mRNA、CEA和CA19 9的阳性率分别为 8.6% (5 / 5 8)、5 .2 % (3 / 5 8)和 3 .4% (2 / 5 8)。检测胸水标本CEA mRNA、CEA和CA19 9指标诊断恶性胸水的特异性分别为 91.4%、94.8%和 96.6% ,敏感性分别为 79.3 %、5 1.7%和 5 5 .2 %。三个指标联检的敏感性为 87.9% (5 1/ 5 8)。结论 在诊断恶性胸水方面 ,CEA mRNA、CEA和CA19 9指标的特异性和敏感性均较高 ,但CEA mRNA指标的敏感性显著性高于CEA和CA19 9指标 (P <0 .0 1) ,三者联检可以进一步提高敏感性。 ObjectiveTo study the applied value on detection of carcinoembryonic antigen mRNA(CEA-mRNA),CEA and CA19-9 for diagnosis and differential diagnosis of malignant dropsy of chest.MethodsThe objects of the study consisted of 58 patients with malignant dropsy of chest and 58 patients with benign dropsy of chest.CEA-mRNA was detected by reverse transcriptase-nested-primer-polymerase chain reaction(RT-NP-PCR),CEA by enzyme-linked immunosorbent assay(ELISA) and CA19-9 by magnetic antibody immunoenzymetric assay(MAIA).ResultsIn the malignant dropsy of chest group,the positive rates of CEA-mRNA,CEA and CA19-9 were 46(79.3%),30(51.7%),and 32(55.2%) respectively. In the benign dropsy of chest group,the positive rates of CEA-mRNA,CEA and CA19-9 were 5(8.6%),3(5.2%) and 2(3.4%).In the diagnosis of malignant dropsy of chest,the specificity was 91.4% to CEA-mRNA, 51.7% to CEA and 55.2% to CA19-9.The sensitivity was 87.9(51/58) when combined detection of CEA-mRNA and CEA and CA19-9 was used.ConclusionCEA-mRNA,CEA and CA19-9 are useful indexes for diagnosis and differential diagnosis of malignant dropsy of chest.The sensitivity of CEA-mRNA is higher than that of CEA and CA19-9(P<0.01).The sensitivity can be improved when combined detection of CEA mRNA and CEA and CA19-9 is conducted.
出处 《中国肿瘤临床与康复》 2002年第5期16-18,共3页 Chinese Journal of Clinical Oncology and Rehabilitation
关键词 CEA-MRNA CEA CA19-9 诊断 恶性胸水 carcinoembryonic antigen mRNA(CEA-mRNA) CEA CA19-9 diagnosis chest dropsy malignant
  • 相关文献

参考文献5

二级参考文献7

共引文献52

同被引文献39

  • 1刘明.一种新的肿瘤标志物:Cyfra21-1[J].国外医学(放射医学核医学分册),1995,19(2):69-70. 被引量:8
  • 2李基业.老年胸腔积液的诊断与鉴别诊断[J].实用老年医学,1997,11(2):62-63. 被引量:2
  • 3万文徽,李吉友.肿瘤标志的临床应用[J].中华医学检验杂志,1997,20(1):49-51. 被引量:180
  • 4陈灏珠.内科学[M].北京:人民卫生出版社,1996.576-584.
  • 5Yonemura Y,Endou Y,Fujimura T,et al.Dignostic value of preoperative RT-PCR-based screening method to detect carcinoemmbryonic antigen-expressing free cancer cells in the peritoneal cavity from patients with gastric cancer [J].ANZ J Surg,2001,71(9):521-528.
  • 6Mimori K,Masuda T,Kataoka A,et al,The clinical significance of detecting small numbers of carcinoma [J].Gan To Kagaku Tyoho,2001,28(6):756-761.
  • 7[9]Stieber P. CYFRA21-1 a new marker in lung cancer[J].Cancer, 1993, 72(4):707~713
  • 8[12]Muraki M,Tohda T. Assessment of serum CYFRA21-1 in lung cancer[J]. Cancer, 1996,77 (6) : 1274
  • 9熊立凡 李树仁.临床检验基础[M](第3版)[M].北京:人民卫生出版社,2004.194-195.
  • 10Dalgleish AG. Tumour markers in malignancies. CA19-9 is useful in several cancer. BMJ,2000,321 (7257) :380.

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部